Aileron Therapeutics Inc (ALRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Operating Expenses | 7,763 | 7,041 | 6,426 | 4,952 | 4,589 |
| Operating Income | -7,763 | -7,041 | -6,426 | -4,952 | -4,589 |
| Other Income | 175 | 176 | 167 | 29 | 32 |
| Pre-tax Income | -7,588 | -6,865 | -6,259 | -4,923 | -4,557 |
| Net Income Continuous | -7,588 | -6,865 | -6,259 | -4,923 | -4,557 |
| Net Income | $-7,588 | $-6,865 | $-6,259 | $-4,923 | $-4,557 |
| EPS Basic Total Ops | -10.40 | 379.40 | -9.00 | -219.60 | -211.60 |
| EPS Basic Continuous Ops | -10.30 | 377.53 | -8.98 | -218.80 | -210.49 |
| EPS Diluted Total Ops | -10.40 | 379.40 | -9.00 | -219.60 | -211.60 |
| EPS Diluted Continuous Ops | -10.30 | 377.53 | -8.98 | -218.80 | -210.49 |
| EBITDA(a) | $-7,761 | $-7,061 | $-6,474 | $-4,929 | $-4,567 |